Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
3.34 USD | -3.47% | +23.25% | -0.60% |
May. 14 | Poseida Therapeutics Q1 Net Loss Narrows, Revenue Rises | MT |
May. 14 | Earnings Flash (PSTX) POSEIDA THERAPEUTICS Reports Q1 Revenue $28.1M | MT |
Financials (USD)
Sales 2024 * | 58.13M | Sales 2025 * | 13.33M | Capitalization | 324M |
---|---|---|---|---|---|
Net income 2024 * | -131M | Net income 2025 * | -226M | EV / Sales 2024 * | 5.58 x |
Net cash position 2024 * | - | Net cash position 2025 * | - | EV / Sales 2025 * | 24.3 x |
P/E ratio 2024 * |
-2.03
x | P/E ratio 2025 * |
-1.86
x | Employees | 335 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 72.34% |
1 day | -3.47% | ||
1 week | +23.25% | ||
Current month | +38.02% | ||
1 month | +64.53% | ||
3 months | -8.74% | ||
6 months | +55.35% | ||
Current year | -0.60% |
Managers | Title | Age | Since |
---|---|---|---|
Kristin Yarema
CEO | Chief Executive Officer | 53 | 23-03-31 |
Johanna Mylet
DFI | Director of Finance/CFO | 37 | 15-05-31 |
Mark Gergen
CHM | Chairman | 61 | 18-01-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Marcea Lloyd
BRD | Director/Board Member | 75 | 18-12-31 |
Cynthia Collins
BRD | Director/Board Member | 65 | 21-07-22 |
Mark Gergen
CHM | Chairman | 61 | 18-01-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
4.87% | 2 M€ | -25.75% | ||
0.03% | 0 M€ | 0.00% | - | |
0.02% | 0 M€ | 0.00% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-16 | 3.345 | -3.32% | 633,055 |
24-05-15 | 3.46 | +18.49% | 1,233,429 |
24-05-14 | 2.92 | +3.91% | 485,661 |
24-05-13 | 2.81 | +6.24% | 238,855 |
24-05-10 | 2.645 | -2.40% | 368,911 |
Delayed Quote Nasdaq, May 16, 2024 at 04:00 pm EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-0.60% | 324M | |
+8.29% | 114B | |
+10.21% | 104B | |
+0.41% | 22.28B | |
-11.90% | 22.41B | |
-5.99% | 19.07B | |
-37.36% | 18B | |
-5.17% | 17.89B | |
+7.70% | 14.28B | |
+37.65% | 12.55B |
- Stock Market
- Equities
- PSTX Stock